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Fluorescent probes have become pivotal tools in biochemical research, enabling longitudinal 
tracking of biomolecules and cells under physiological conditions. Fluorescence-based 
technologies have progressed to create exciting avenues in molecular imaging, where multiple 
biological events can be simultaneously visualized in situ in living organisms. Fluorophores 
can be broadly categorized into labeling or activatable probes, depending on their spectral 
properties. Initially, fluorophores were mainly employed as bright labels to monitor the 
localization of specific proteins or cells. More recently, fluorescent probe development has 
focused on the design of activatable fluorophores that ‘turn-on’ in well-defined environments, 
enhancing signal-to-noise ratios and boosting sensitivity.1 In addition to being powerful 
analytical tools to detect metabolites and/or discriminate subpopulations of cells, activatable 
fluorophores have started to be employed in mechanistic studies for drug discovery. These 
range from assays at the molecular level to map drug-binding sites in target proteins2 to 
profiling assays in therapeutically-relevant subsets of cells.3 
Among many immune cells found in our body, macrophages display a broad range of functions 
and a remarkable capacity to adapt to their environment. Macrophages play critical roles in 
tissue repair and remodelling, including the tumour microenvironment and the orchestration of 
the host immune response to infection. The activity of macrophages is regarded as a 
biomarker for diagnostic and therapeutic exploitation in many pathologies, and several 
fluorescent probes have been designed as macrophage reporters.4 Such probes, however, 
provide generic readouts of macrophage activity and cannot modulate the function of 
subpopulations of cells. The diversity of phenotypes of macrophages represents a major 
challenge for chemists since macrophage-targeting probes must discriminate between 
closely-related subpopulations that coexist in the same tissue. This becomes particularly 
important when subpopulations of macrophages have divergent in vivo functions (e.g., 
proinflammatory vs anti-inflammatory macrophages in tissue regeneration). Such studies had 
not been possible to date with non-encoded chemical probes because of the challenge of 
producing molecules that target only defined macrophage subsets in vivo. 
The recent prodrug-fluorophore conjugates combining small molecule drugs and activatable 
fluorophores represent a remarkable addition to our chemical toolbox for studying the 
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mechanisms of action of drugs in vivo.5 These prodrug-fluorophore conjugates exploit the 
hydrolytic activity in the phagosomes of macrophages as the bioresponsive trigger to 
distinguish between proinflammatory and anti-inflammatory macrophages. Macrophages 
enclose a relatively high number of intracellular phagosomes, with a broad range of pH values 
(i.e., from 6.5 to 4.5) depending on their maturation state and phagocytic activity. The 
combination of activatable profluorophores and prodrugs responding to the phagosomal pH 
rendered conjugates that released bright fluorophores and cytotoxic drugs only in 
proinflammatory M1 macrophages. This approach has advantages over conventional 
strategies: 1) from the therapeutic point of view, improved efficacy because prodrugs are only 
active in targeted subpopulations with fewer side effects; 2) for mechanistic studies, the 
simultaneous release of fluorophores and drugs enables to image the action of the drugs in 
real time. 
The first example of these conjugates combined a pH-activatable BODIPY profluorophore and 
the drug doxorubicin (i.e., a DNA-intercalating cytotoxic agent) (Figure 1A). Their coupling 
through a pH-sensitive N-acylhydrazone group afforded poorly fluorescent and inactive 
conjugates. However, when these molecules localized in the acidic phagosomes of M1 
macrophages, they released cytotoxic doxorubicin and a green fluorophore detectable by flow 
cytometry and confocal microscopy. The selectivity of the conjugates for M1 macrophages vs 
other macrophages was validated in cell mixtures. More importantly, the conjugates were used 
to image and modulate macrophage function in vivo, targeting proinflammatory macrophages 
in a zebrafish model of tissue repair, whereby the tail fin was amputated and its regeneration 
was monitored over time. The targeted release of the ‘fluorophore + drug’ cocktail highlighted 
the proregenerative role of specific macrophages in vivo (Figure 1B). Another remarkable 
feature of these molecules is their potential for translational studies in human cells. This is 
critical in macrophages since notable differences have been reported between murine and 
human species. Ex vivo assays in monocyte-derived macrophages from human peripheral 
blood confirmed the application of these conjugates for future translational studies.  
This new chemical strategy opens multiple opportunities for biochemical studies in cells that 
can differentiate into various lineages or display variable phenotypes depending on their 
microenvironment (e.g., pluripotent cells). The expansion of this platform to other drugs and 
fluorophores will help to design targeted chemical immunomodulatory agents for specific 
subpopulations of cells, providing new insights on the mechanisms behind cell reprogramming 
and generating better therapies for immune-related disorders.  
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Figure 1. A) Chemical structures of prodrug-fluorophore conjugates and the outcome of their 
activation in M1 macrophages. B) Bright field (left) and fluorescence (middle and right) 
confocal microscope images of live transgenic zebrafish. All macrophages displayed red 
fluorescence (mCherry label), however green fluorescence was only detected in regenerating 
tissues where macrophages had been activated with lipopolysaccharide to induce the release 
of doxorubicin and the BODIPY fluorophore (right). Scale bar: 65 µm. 
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